• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Pfizer-licensed Cardiovascular Drug Reduces Triglycerides in Phase II

cafead

Administrator
Staff member
  • cafead   Nov 26, 2021 at 09:12: PM
via A cardiovascular drug Pfizer licensed from Akcea Therapeutics in 2019 hit the mark in a Phase IIb dose-ranging study in patients with elevated non-HDL-C and triglycerides.

article source